The global biotechnology and medical industry is changing rapidly, and technology leaders such as Apple, Google, Facebook, and Amazon are actively deploying. Taiwan's medical technology has also frequently demonstrated its advancement with the future of technology. The "2019 Future Technology Exhibition" sponsored by the Ministry of Science and Technology, how to expand the penetration of AI and AIoT in the field of biotechnology and medical care, the two major themes of "Biotechnology and New Drugs" and "Medical Materials" in the six major technologies, including 28 forward-looking scientific research results. From December 5th to 8th, we will witness Taiwan's excellent advantages in the global biomedical competition.
AI and AIoT have expanded and penetrated into the field of biotechnology and medical care. Among the six major technologies, the two Special Database themes of "Biotechnology and New Drugs" and "Medical Materials", Photo credit: Ministry of Science and Technology AI and AIoT have expanded and penetrated into the field of biotechnology and medical care. Among the six major technologies, the two themes of "Biotechnology and New Drugs" and "Medical Materials" include 28 forward-looking scientific research achievements In the theme of "Biotechnology and New Drugs", the two innovative technologies of "glycosylated hemagglutinin" and "deglycosylated hemagglutinin" are quite eye-catching.
It can effectively inhibit the high mutation rate and lethal rate of new influenza viruses such as H5N1 and H7N9. In addition, the platform "Application of Multifunctional Thin-Shell Nanoparticles in Antiviral and Precise Anticancer Vaccines" was launched by Dr. Hu Zheming's research team at the Academia Sinica to solve the bottleneck in the preparation of cancer vaccines. The research team of Professo